Form 3 Filing for Matthew Baker Turner

This filing details restricted stock awards and stock options granted to Matthew Baker Turner, President of Patient Affordability at Paysign, Inc. The awards include common stock with staggered vesting dates in 2024, 2026, 2027, and 2028, as well as stock options with a vesting schedule based on the grant date anniversary. The filing also includes a Limited Power of Attorney, appointing Robert Strobo and Mark Newcomer to handle Section 16 reporting obligations on behalf of Mr. Turner. This power of attorney authorizes them to prepare and file necessary forms with the SEC, obtain transaction information, and perform other related acts. It clarifies that this delegation does not relieve Mr. Turner of his reporting responsibilities.